Treatment with Growth Hormone
Widespread interest in the use of human growth hormone followed M. S. Raben 16 Growth hormone therapy has been remarkably free from side effects. While anorexia and oliguria were reported during early studies on the acute metabolic effects of growth hormone in man,'7 they have not been a problem during long-term therapy. Growth hormone has a diabetogenic action, but impaired carbohydrate tolerance has not been reported as a result of the long-term treatment of growthhormone-deficient children. The low blood sugar values commonly found in such patients return to normal as a result of treatment and symptomatic hypoglycaemia is relieved. '8 19 A number of patients with craniopharyngioma have been treated with growth hormone after partial resection of the tumour; there is no evidence to suggest that such treatment accelerates growth of any residual tumour. Occasionally the patient's rate of growth returns to normal after surgical resection of a craniopharyngioma20 and growth hormone therapy is then not indicated.
In some series of patients treated with growth hormone a high incidence of anti-growth-hormone antibodies has been found.14 15 21 22 In most cases the antibodies have been of low titre and do not appear to have been of clinical significance. Rashes and other evidence of hypersensitivity have not been noted, and the patients have continued to respond to treatment. In a minority of patients very high antibody titres have developed, and in many of these cases growth hormone was no longer effective.'4 15 22 23 In some instances the antibody titre fell when treatment was discontinued, and further growth hormone therapy was successful.22 24 In others the high antibody titres persisted and treatment had to be abandoned. 22 Microaneurysms in the eyes of patients with diabetic retinopathy were reported back in 1879,1 but it was not until A. J. Ballantyne and A. Loewenstein2 described them again in 1943 that their relationship with diabetes was firmly established. They are not specific to diabetes and occur in a number of unrelated conditions such as macroglobulinaemia, hypertension, venous occlusion, sickle-cell disease, and pulseless disease. 3 Clinically they are difficult to distinguish from small haemorrhages, and the two are rightly regarded together as "dots" and "blots," or the "sanguinolent spots" of K. Lunbaek.4 If few in number, they are diffusely scattered in the fundus. In more advanced retinopathy they usually occur in clusters of small numbers away from large vessels, more commonly in the posterior pole, and they vary somewhat in size. They can also be found in the centre of rings of hard exudates and may contribute to their formation.
Microscopically the majority are seen as diverticula of the basement membrane of capillaries,5 but some may contain hyaline material in the wall6 or may be hypercellular owing to endothelial proliferation. The pathogenesis is uncertain. A proportion are due to the formation of pouches in the basement membrane of abnormal capillaries, and as they tend to be adjacent to areas of capillary closure anoxia probably plays a part. Endothelial proliferation is thought to be a secondary phenomenon and not the primary cause of their formation.5 A small number arise as a result of capillaries forming U-shaped loops with resultant disappearance of the adjacent walls, but stagnation and engorgement, a feature of the microcirculation in diabetic retinopathy, may also be important factors.5
Much of our knowledge has stemmed from histological studies,8 9 but the application of fluorescence angiography to the study of diabetic retinopathy'0 has yielded more useful information still. Where both the fluorescence angiogram and histological preparations were available it was possible to correlate many of the features." 12 Thus microaneurysms were found to surround areas not perfused by capillaries, and histologically these areas were seen to contain closed acellular capillaries. Fluorescein angiography showed many more microaneurysms than were seen clinically, and in an admirable study of their rate of formation and disappearance E. M. Kohner and C. T. Dollery'2 found that some were perfused intermittently. They studied the serial angiograms of 21 patients chosen out of 100 who had had serial fluorescein angiography, because they had at least three angiograms of good quality in the follow-up period of 18 months. They counted the microaneurysms in a given area of the retina by mapping them on a diagram. By repeating the process serially and plotting those that had disappeared and appeared afresh, they were able to calculate the monthly rate of formation and disappearance of the lesions. Their patients were divided into three groups: "mild" cases, requiring no specific treatment for their retinopathy; "severe" cases suitable for treatment by pituitary ablation but not subjected to it; and a similar group treated by pituitary ablation. They did not find a statistically significant difference between the rates of formation and disappearance of microaneurysms in cases with "severe" and "mild" retinopathy, but they did find a significant difference in the rates between those with "severe" retinopathy and those who had been treated by pituitary ablation. In the latter group, both the rate of formation was slower and the rate of disappearance greater than in the untreated group.
As well as recording a quantitative way of studying the course of microaneurysms this study supplied some evidence to support claims that pituitary ablation has a beneficial effect on diabetic retinopathy. Despite the difficulty of distinguishing microaneurysms from bends in capillaries, such a quantitative method of assessment is a useful contribution to studying their role in diabetic retinopathy and in assessing the effect of different types of treatment.
